K., Vadla, G
GSH depletion triggered by the Nrf2/ATF3/4/ChaC1 pathway appears to be the primary factor inducing death in drug-resistant tumor cells (138), positioning ChaC1 as a key target for certain potential anti-tumor drugs such as busatol (139) and glaucocalyxin A (140)
Full AI Image Prompt: Create a clinical safety infographic titled GHK-Cu Safety Considerations by Route. Use a three-column matrix labeled Topical products, Wound-care study context, and Injectable or compounded preparations. Under topical products, include skin irritation, allergic reaction, and formulation sensitivity. Under wound-care study context, include study exclusions, copper or peptide sensitivity, and dressings or adhesives. Under injectable or compounded preparations, include limited human safety data, peptide-related impurities, aggregation risk, and immunogenicity risk. Use a calm medical style, white background, simple icons, and subtle copper-blue accents
Athletes subject to anti-doping rules should consult their sports governing body before any research involving peptide compounds
You will use the entire contents within 4 to 6 weeks, well within the stability window
These enhanced formulations are widely used in aesthetic medicine and have shown promising results when administered correctly and consistently